Editas Medicine (EDIT) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Editas Medicine (EDIT) over the last 7 years, with Q3 2025 value amounting to -$0.28.
- Editas Medicine's EPS (Weighted Average and Diluted) rose 6266.67% to -$0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.38, marking a year-over-year increase of 629.92%. This contributed to the annual value of -$2.88 for FY2024, which is 4254.78% down from last year.
- Latest data reveals that Editas Medicine reported EPS (Weighted Average and Diluted) of -$0.28 as of Q3 2025, which was up 6266.67% from -$0.63 recorded in Q2 2025.
- Editas Medicine's 5-year EPS (Weighted Average and Diluted) high stood at -$0.21 for Q4 2023, and its period low was -$0.92 during Q1 2025.
- In the last 5 years, Editas Medicine's EPS (Weighted Average and Diluted) had a median value of -$0.74 in 2022 and averaged -$0.67.
- As far as peak fluctuations go, Editas Medicine's EPS (Weighted Average and Diluted) tumbled by 57500.0% in 2021, and later skyrocketed by 7613.64% in 2023.
- Over the past 5 years, Editas Medicine's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.61 in 2021, then plummeted by 44.26% to -$0.88 in 2022, then soared by 76.14% to -$0.21 in 2023, then crashed by 162.52% to -$0.55 in 2024, then soared by 49.21% to -$0.28 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.28 in Q3 2025, compared to -$0.63 in Q2 2025 and -$0.92 in Q1 2025.